4D-Nucleofector^® LV Unit for cell and gene therapy applications – Benefits and how it works

4D-Nucleofector® LV Unit for Cell and Gene Therapy Applications – Benefits and How it Works

From this video learn how it works and its benefits for cell and gene therapy manufacturing.

Watch this 15-min video, created in collaboration with BioInsights, to discover the 4D-Nucleofector® LV Unit for efficient large-scale transfection in research or GMP environments.

Join Dr. Andrea Toell, Senior Product Manager, and Timo Gleissner, Associate Director Engineering, as they

Demonstrate the device in a lab setting
Discuss the technology’s benefits for ex vivo genetic modification in cell and gene therapy applications

Tune in and watch the 4D-Nucleofector^® LV Unit live in action.

4D Nucleofector^® LV Unit PRO

The LV Unit PRO is optimized for the delivery of clinical relevant cargos and efficiently supports closed and scalable transfection of up to 1 billion cells from research to GMP manufacturing.

Learn more

Nucleofector^® Technology

An electroporation-based transfection platform for the non-viral, ex-vivo genetic modification of human primary cells in research or GMP environments. Ranging from small to large scale formats, allowing you to easily translate research results into therapeutic applications.

Learn more

The next scale in cell and gene therapy

Built on GMP-grade quality and rich regulatory and process expertise, TheraPEAK^® Products help you effectively plan the development of your therapy so you can more rapidly bring it to patients.

Learn more

4D-Nucleofector® LV Unit for cell and gene therapy applications – Benefits and how it works